Macau, China vs Norway: The number of people with susceptibility test result for rifampicin
Macau, China
98.97
in 2021
Norway
98.57
in 2021
Macau, China rank
34th
Norway rank
36th
The number of people with susceptibility test result for rifampicin over time
- Macau, China
- Norway
How they compare
Macau, China currently reports 98.97 against 98.57 in Norway, a difference of 0.4.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Norway ahead.
Macau, China ranks 34th and Norway ranks 36th of 146 countries.
Macau, China has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Macau, China | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.98 | 95.09 | 2.88 | Macau, China |
| 2020s | 99.25 | 98.68 | 0.5731 | Macau, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Macau, China or Norway?
- Macau, China, at 98.97 against 98.57 in Norway as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Macau, China and Norway?
- 0.4, with Macau, China ahead.
- How many years of comparable data are there for Macau, China and Norway?
- 5 years are reported by both, from 2017 to 2021.
- How do Macau, China and Norway rank globally for the number of people with susceptibility test result for rifampicin?
- Macau, China ranks 34th and Norway ranks 36th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.